Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma

Alissa A. Thomas, Lauren E. Abrey, Robert Terziev, Jeffrey Raizer, Nina L. Martinez, Peter Forsyth, Nina Paleologos, Matthew Matasar, Craig S. Sauter, Craig Moskowitz, Stephen D. Nimer, Lisa M. Deangelis, Thomas Kaley, Sean Grimm, David N. Louis, J. Gregory Cairncross, Katherine S. Panageas, Samuel Briggs, Geraldine Faivre, Nimish A. MohileJayesh Mehta, Philip Jonsson, Debyani Chakravarty, Jianjiong Gao, Nikolaus Schultz, Cameron W. Brennan, Jason T. Huse, Antonio Omuro*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS